The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease
- PMID: 16369839
- DOI: 10.1007/s10048-005-0023-z
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease
Abstract
An expanded polyglutamine stretch in the huntingtin protein has been identified as the pathogenetic cause of Huntington's disease (HD). Although the length of the expanded polyglutamine repeat is inversely correlated with the age-at-onset, additional genetic factors are thought to modify the variance in the disease onset. As linkage analysis suggested a modifier locus on chromosome 4p, we investigated the functional relevance of S18Y polymorphism of the ubiquitin carboxy-terminal hydrolase L1 in 946 Caucasian HD patients. In this group, the allelic variation on locus S18Y is responsible for 1.1% of the variance in the HD age-at-onset, and the rare Y allele is associated with younger-aged cases.
Similar articles
-
Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.J Med Genet. 2007 Jan;44(1):44-50. doi: 10.1136/jmg.2006.045153. Epub 2006 Oct 3. J Med Genet. 2007. PMID: 17018562 Free PMC article.
-
Polymorphism of HD and UCHL-1 genes in Huntington's disease.J Clin Neurosci. 2009 Nov;16(11):1473-7. doi: 10.1016/j.jocn.2009.03.027. Epub 2009 Aug 14. J Clin Neurosci. 2009. PMID: 19683447
-
Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease.Neurosci Lett. 2002 Aug 2;328(1):1-4. doi: 10.1016/s0304-3940(02)00231-8. Neurosci Lett. 2002. PMID: 12123845
-
Huntington's disease: translating a CAG repeat into a pathogenic mechanism.Curr Opin Neurobiol. 1996 Oct;6(5):638-43. doi: 10.1016/s0959-4388(96)80097-3. Curr Opin Neurobiol. 1996. PMID: 8937828 Review.
-
Bioenergetics in Huntington's disease.Ann N Y Acad Sci. 1999;893:203-13. doi: 10.1111/j.1749-6632.1999.tb07827.x. Ann N Y Acad Sci. 1999. PMID: 10672239 Review.
Cited by
-
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.Biochem Biophys Res Commun. 2012 Aug 3;424(3):404-8. doi: 10.1016/j.bbrc.2012.06.120. Epub 2012 Jul 3. Biochem Biophys Res Commun. 2012. PMID: 22771793 Free PMC article.
-
A Glimpse of Molecular Biomarkers in Huntington's Disease.Int J Mol Sci. 2022 May 12;23(10):5411. doi: 10.3390/ijms23105411. Int J Mol Sci. 2022. PMID: 35628221 Free PMC article. Review.
-
Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington’s disease pathogenesis.Mamm Genome. 2012 Jun;23(5-6):367-77. doi: 10.1007/s00335-012-9391-5. Mamm Genome. 2012. PMID: 22290451 Free PMC article.
-
Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.Hum Genet. 2006 Sep;120(2):285-92. doi: 10.1007/s00439-006-0221-2. Epub 2006 Jul 18. Hum Genet. 2006. PMID: 16847693
-
Genetic analysis of the GRIK2 modifier effect in Huntington's disease.BMC Neurosci. 2006 Sep 7;7:62. doi: 10.1186/1471-2202-7-62. BMC Neurosci. 2006. PMID: 16959037 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous